Insiders Pile Into Holdings of XBI ETF
March 06, 2015 at 09:55 AM EST
A look at the weighted underlying holdings of the SPDR S&P Biotech ETF (XBI) shows an impressive 21.2% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying Halozyme Therapeutics Inc (HALO), which makes up 2.01% of the SPDR S&P Biotech ETF (XBI), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data.